Wockhardt Limited (WOCKPHARMA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Wockhardt Limited (WOCKPHARMA) has a cash flow conversion efficiency ratio of -0.005x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-220.00 Million ≈ $-2.38 Million USD) by net assets (Rs46.57 Billion ≈ $503.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see WOCKPHARMA company net worth for the company's overall valuation and market capitalisation.
Wockhardt Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Wockhardt Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Wockhardt Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wockhardt Limited ranked by their cash flow conversion efficiency. Explore Wockhardt Limited cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Centre Testing Intl Shenzhen
SHE:300012
|
0.052x |
|
Anhui Zhongding Sealing Parts Co Ltd
SHE:000887
|
0.040x |
|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
0.073x |
|
Guangzhou Haige Communications Group Incorporated Co
SHE:002465
|
-0.019x |
|
Rubis SCA
PA:RUI
|
0.102x |
|
Lazard Ltd
NYSE:LAZ
|
0.291x |
|
Changsha Jingjia Microelectronics Co Ltd
SHE:300474
|
-0.013x |
|
Atmus Filtration Technologies Inc.
NYSE:ATMU
|
0.094x |
Annual Cash Flow Conversion Efficiency for Wockhardt Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Wockhardt Limited from 2005 to 2025. View Wockhardt Limited stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs46.57 Billion ≈ $503.64 Million |
Rs-220.00 Million ≈ $-2.38 Million |
-0.005x | -107.90% |
| 2024-03-31 | Rs36.62 Billion ≈ $396.03 Million |
Rs2.19 Billion ≈ $23.68 Million |
0.060x | +43.14% |
| 2023-03-31 | Rs36.62 Billion ≈ $396.03 Million |
Rs1.53 Billion ≈ $16.55 Million |
0.042x | -57.49% |
| 2022-03-31 | Rs42.02 Billion ≈ $454.43 Million |
Rs4.13 Billion ≈ $44.66 Million |
0.098x | +228.63% |
| 2021-03-31 | Rs37.60 Billion ≈ $406.66 Million |
Rs-2.87 Billion ≈ $-31.07 Million |
-0.076x | -136.00% |
| 2020-03-31 | Rs30.57 Billion ≈ $330.65 Million |
Rs6.49 Billion ≈ $70.18 Million |
0.212x | +247.89% |
| 2019-03-31 | Rs30.05 Billion ≈ $324.94 Million |
Rs1.83 Billion ≈ $19.83 Million |
0.061x | +185.08% |
| 2018-03-31 | Rs31.98 Billion ≈ $345.84 Million |
Rs684.40 Million ≈ $7.40 Million |
0.021x | +129.53% |
| 2017-03-31 | Rs37.19 Billion ≈ $402.16 Million |
Rs-2.69 Billion ≈ $-29.14 Million |
-0.072x | -539.46% |
| 2016-03-31 | Rs43.43 Billion ≈ $469.66 Million |
Rs716.10 Million ≈ $7.74 Million |
0.016x | -82.07% |
| 2015-03-31 | Rs38.59 Billion ≈ $417.37 Million |
Rs3.55 Billion ≈ $38.39 Million |
0.092x | -76.84% |
| 2014-03-31 | Rs37.18 Billion ≈ $402.05 Million |
Rs14.76 Billion ≈ $159.66 Million |
0.397x | -29.92% |
| 2013-03-31 | Rs27.04 Billion ≈ $292.45 Million |
Rs15.32 Billion ≈ $165.72 Million |
0.567x | -29.62% |
| 2012-03-31 | Rs14.71 Billion ≈ $159.09 Million |
Rs11.84 Billion ≈ $128.08 Million |
0.805x | +41.30% |
| 2011-03-31 | Rs11.26 Billion ≈ $121.82 Million |
Rs6.42 Billion ≈ $69.41 Million |
0.570x | +347.19% |
| 2010-03-31 | Rs8.35 Billion ≈ $90.33 Million |
Rs-1.93 Billion ≈ $-20.82 Million |
-0.231x | -288.42% |
| 2009-03-31 | Rs10.18 Billion ≈ $110.06 Million |
Rs1.25 Billion ≈ $13.46 Million |
0.122x | -58.70% |
| 2008-03-31 | Rs12.74 Billion ≈ $137.73 Million |
Rs3.77 Billion ≈ $40.79 Million |
0.296x | +67.51% |
| 2007-03-31 | Rs10.66 Billion ≈ $115.32 Million |
Rs1.89 Billion ≈ $20.39 Million |
0.177x | -29.49% |
| 2006-03-31 | Rs8.16 Billion ≈ $88.26 Million |
Rs2.05 Billion ≈ $22.13 Million |
0.251x | -22.04% |
| 2005-03-31 | Rs6.17 Billion ≈ $66.68 Million |
Rs1.98 Billion ≈ $21.45 Million |
0.322x | -- |
About Wockhardt Limited
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH… Read more